nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

26.11.2021 | Head and Neck

Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma

verfasst von: Haixia Wang, Tianliang Yu, Limin Mao

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The prognostic and clinicopathological value of placental-Cadherin (CDH3) in multiple cancers is controversial. The diagnostic significance and functional mechanism of CDH3 in tongue squamous cell carcinoma (TSCC) have not been thoroughly investigated. This study aims to clarify the potential of CDH3 as biomarker for TSCC.

Methods

Here, meta-analysis, bioinformatics, along wet-lab techniques were employed to evaluate the diagnostic, as well as the prognostic value of CDH3 in diverse types of cancers, especially TSCC. Meta-analysis was used to determine the influence of CDH3 on prognostic and clinicopathological features in numerous cancers. Molecular biology function was used to investigate the role of CDH3 in TSCC cells. The relationship of CDH3 with tumor-infiltrating immune cells (TIICs) in TSCC was assessed using CIBERSORT. Moreover, gene set enrichment analysis (GSEA) was done based on TCGA. Besides, the hub genes and associated cascades were uncovered based on gene co-expression with CDH3.

Results

CDH3 upregulation correlated with worse overall survival and disease-free survival in various cancers. CDH3 was validated as an independent risk factor for HNSC and was linked to the onset of tumors, tumor stage, and infiltration depth. CDH3 silencing inhibited cell growth and induced apoptosis of the CAL-27 cell line. CDH3 expression level correlated with infiltration by macrophages, T cells, T cell regulatory cells (Tregs), and plasma cells in TSCC. GSEA revealed that CDH3 influences multiple cancer-associated cascades. Besides, CBX3, CCHCR1, along NFYC were identified as the core hub genes for CDH3.

Conclusion

We identified CDH3 as a pan-cancer gene with potential prognostic and diagnostic significance in various cancers, particularly in TSCC, where it is tumorigenic.

Jin Y, Yang Y (2019) Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma. Biosci Rep 39(7):BSR0191612. https://doi.org/10.1042/BSR20191612CrossRef

Perumal V, Corica T, Dharmarajan AM, Sun Z, Dhaliwal SS, Dass CR, Dass J (2019) Circulating tumour cells (CTC) Head and neck cancer and radiotherapy; future perspectives. Cancers. https://doi.org/10.3390/cancers11030367CrossRefPubMedPubMedCentral

Zhou H, Zhang J, Guo L, Nie J, Zhu C, Ma X (2018) The value of narrow band imaging in diagnosis of head and neck cancer: a meta-analysis. Sci Rep 8(1):515. https://doi.org/10.1038/s41598-017-19069-0CrossRefPubMedPubMedCentral

Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, Luttmann S, Kraywinkel K, Brenner H, Group GCSW (2018) Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral Oncol 76:8–15. https://doi.org/10.1016/j.oraloncology.2017.11.015CrossRefPubMed

Zhu P, He L, Li Y, Huang W, Xi F, Lin L, Zhi Q, Zhang W, Tang YT, Geng C, Lu Z, Xu X (2014) OTG-snpcaller: an optimized pipeline based on TMAP and GATK for SNP calling from ion torrent data. PLoS ONE 9(5):e97507. https://doi.org/10.1371/journal.pone.0097507CrossRefPubMedPubMedCentral

Gardner SN, Frey KG, Redden CL, Thissen JB, Allen JE, Allred AF, Dyer MD, Mokashi VP, Slezak TR (2015) Targeted amplification for enhanced detection of biothreat agents by next-generation sequencing. BMC Res Notes 8:682. https://doi.org/10.1186/s13104-015-1530-0CrossRefPubMedPubMedCentral

Hulpiau P, van Roy F (2009) Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol 41(2):349–369. https://doi.org/10.1016/j.biocel.2008.09.027CrossRefPubMed

Sasaki M, Akiyama-Oda Y, Oda H (2017) Evolutionary origin of type IV classical cadherins in arthropods. BMC Evol Biol 17(1):142. https://doi.org/10.1186/s12862-017-0991-2CrossRefPubMedPubMedCentral

Cappellesso R, Marioni G, Crescenzi M, Giacomelli L, Guzzardo V, Mussato A, Staffieri A, Martini A, Blandamura S, Fassina A (2015) The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma. Histopathology 67(4):491–500. https://doi.org/10.1111/his.12668CrossRefPubMed

10.

Franz L, Nicole L, Frigo AC, Ottaviano G, Gaudioso P, Saccardo T, Visconti F, Cappellesso R, Blandamura S, Fassina A, Marioni G (2021) Epithelial-to-mesenchymal transition and neoangiogenesis in laryngeal squamous cell carcinoma. Cancers. https://doi.org/10.3390/cancers13133339CrossRefPubMedPubMedCentral

11.

Kourtidis A, Lu R, Pence LJ, Anastasiadis PZ (2017) A central role for cadherin signaling in cancer. Exp Cell Res 358(1):78–85. https://doi.org/10.1016/j.yexcr.2017.04.006CrossRefPubMedPubMedCentral

12.

Nose A, Takeichi M (1986) A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol 103(6 Pt 2):2649–2658. https://doi.org/10.1083/jcb.103.6.2649CrossRefPubMed

13.

Vieira AF, Paredes J (2015) P-cadherin and the journey to cancer metastasis. Mol Cancer 14:178. https://doi.org/10.1186/s12943-015-0448-4CrossRefPubMedPubMedCentral

14.

Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC (2005) P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res Off J Am Assoc Cancer Res 11(16):5869–5877. https://doi.org/10.1158/1078-0432.CCR-05-0059CrossRef

15.

Shimoyama Y, Hirohashi S (1991) Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 51(8):2185–2192PubMed

16.

Taniuchi K, Nakagawa H, Hosokawa M, Nakamura T, Eguchi H, Ohigashi H, Ishikawa O, Katagiri T, Nakamura Y (2005) Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res 65(8):3092–3099. https://doi.org/10.1158/0008.5472.CAN-04-3646CrossRefPubMed

17.

Bauer R, Valletta D, Bauer K, Thasler WE, Hartmann A, Muller M, Reichert TE, Hellerbrand C (2014) Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity. Int J Clin Exp Pathol 7(9):6125–6132PubMedPubMedCentral

18.

Smythe WR, Williams JP, Wheelock MJ, Johnson KR, Kaiser LR, Albelda SM (1999) Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer. Lung Cancer 24(3):157–168. https://doi.org/10.1016/s0169-5002(99)00032-xCrossRefPubMed

19.

Van Marck V, Stove C, Van Den Bossche K, Stove V, Paredes J, Vander Haeghen Y, Bracke M (2005) P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res 65(19):8774–8783. https://doi.org/10.1158/0008-5472.CAN-04-4414CrossRefPubMed

20.

Hsiao TF, Wang CL, Wu YC, Feng HP, Chiu YC, Lin HY, Liu KJ, Chang GC, Chien KY, Yu JS, Yu CJ (2020) Integrative omics analysis reveals soluble cadherin-3 as a survival predictor and an early monitoring marker of EGFR tyrosine kinase inhibitor therapy in lung cancer. Clin Cancer Res Off J Am Assoc Cancer Res 26(13):3220–3229. https://doi.org/10.1158/1078-0432.CCR-19-3972CrossRef

21.

Li L, Yu S, Wu Q, Dou N, Li Y, Gao Y (2019) KLF4-mediated CDH3 upregulation suppresses human hepatoma cell growth and migration via GSK-3beta signaling. Int J Biol Sci 15(5):953–961. https://doi.org/10.7150/ijbs.30857CrossRefPubMedPubMedCentral

22.

Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF (2012) Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol Off J Am Soc Clin Oncol 30(21):2678–2683. https://doi.org/10.1200/JCO.2011.37.8539CrossRef

23.

Al Absi A, Wurzer H, Guerin C, Hoffmann C, Moreau F, Mao X, Brown-Clay J, Petrolli R, Casellas CP, Dieterle M, Thiery JP, Chouaib S, Berchem G, Janji B, Thomas C (2018) Actin cytoskeleton remodeling drives breast cancer cell escape from natural killer-mediated cytotoxicity. Cancer Res 78(19):5631–5643. https://doi.org/10.1158/0008-5472.CAN-18-0441CrossRefPubMed

24.

Insua-Rodriguez J, Oskarsson T (2016) The extracellular matrix in breast cancer. Adv Drug Deliv Rev 97:41–55. https://doi.org/10.1016/j.addr.2015.12.017CrossRefPubMed

25.

Lin S, Huang C, Gunda V, Sun J, Chellappan SP, Li Z, Izumi V, Fang B, Koomen J, Singh PK, Hao J, Yang S (2019) Fascin controls metastatic colonization and mitochondrial oxidative phosphorylation by remodeling mitochondrial actin filaments. Cell Rep 28(11):2824–2836. https://doi.org/10.1016/j.celrep.2019.08.011CrossRefPubMedPubMedCentral

26.

Park JS, Burckhardt CJ, Lazcano R, Solis LM, Isogai T, Li L, Chen CS, Gao B, Minna JD, Bachoo R, DeBerardinis RJ, Danuser G (2020) Mechanical regulation of glycolysis via cytoskeleton architecture. Nature 578(7796):621–626. https://doi.org/10.1038/s41586-020-1998-1CrossRefPubMedPubMedCentral

27.

Shen J, Cao B, Wang Y, Ma C, Zeng Z, Liu L, Li X, Tao D, Gong J, Xie D (2018) Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer. J Exp Clin Cancer Res CR 37(1):175. https://doi.org/10.1186/s13046-018-0850-zCrossRefPubMed

28.

Wortzel I, Dror S, Kenific CM, Lyden D (2019) Exosome-mediated metastasis: communication from a distance. Dev Cell 49(3):347–360. https://doi.org/10.1016/j.devcel.2019.04.011CrossRefPubMed

29.

Sathyanarayana UG, Moore AY, Li L, Padar A, Majmudar K, Stastny V, Makarla P, Suzuki M, Minna JD, Feng Z, Gazdar AF (2007) Sun exposure related methylation in malignant and non-malignant skin lesions. Cancer Lett 245(1–2):112–120. https://doi.org/10.1016/j.canlet.2005.12.042CrossRefPubMed

30.

Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M (2003) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63(13):3735–3742PubMed

31.

Vered M, Lehtonen M, Hotakainen L, Pirila E, Teppo S, Nyberg P, Sormunen R, Zlotogorski-Hurvitz A, Salo T, Dayan D (2015) Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study. BMC Cancer 15:25. https://doi.org/10.1186/s12885-015-1030-6CrossRefPubMedPubMedCentral

32.

Collins RJ, Jiang WG, Hargest R, Mason MD, Sanders AJ (2015) EPLIN: a fundamental actin regulator in cancer metastasis? Cancer Metastasis Rev 34(4):753–764. https://doi.org/10.1007/s10555-015-9595-8CrossRefPubMedPubMedCentral

33.

Kong J, Shen S, Zhang Z, Wang W (2020) Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis. Cancer Biomark Sect A Dis Markers 27(4):505–517. https://doi.org/10.3233/CBM-190038CrossRef

34.

Meng W, Takeichi M (2009) Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 1(6):a002899. https://doi.org/10.1101/cshperspect.a002899CrossRefPubMedPubMedCentral

35.

Gnagnarella P, Raimondi S, Aristarco V, Johansson HA, Bellerba F, Corso F, Gandini S (2020) Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol 1268:53–114. https://doi.org/10.1007/978-3-030-46227-7_4CrossRefPubMed

36.

Matsui T, Shigeta T, Umeda M, Komori T (2015) Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 120(4):436–442. https://doi.org/10.1016/j.oooo.2015.06.002CrossRefPubMed

37.

Yang X, Pang Y, Zhang J, Shi J, Zhang X, Zhang G, Yang S, Wang J, Hu K, Wang J, Jing H, Ke X, Fu L (2019) High expression levels of ACTN1 and ACTN3 indicate unfavorable prognosis in acute myeloid leukemia. J Cancer 10(18):4286–4292. https://doi.org/10.7150/jca.31766CrossRefPubMedPubMedCentral

38.

Matsumura H, Mohri Y, Binh NT, Morinaga H, Fukuda M, Ito M, Kurata S, Hoeijmakers J, Nishimura EK (2016) Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science 351(6273):aad4395. https://doi.org/10.1126/science.aad4395CrossRefPubMed

39.

Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9(4):265–273. https://doi.org/10.1038/nrc2620CrossRefPubMed

40.

Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res BCR 12(5):R68. https://doi.org/10.1186/bcr2635CrossRefPubMed

41.

Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871–890. https://doi.org/10.1016/j.cell.2009.11.007CrossRefPubMed

42.

Shen Y, Xu J, Pan X, Zhang Y, Weng Y, Zhou D, He S (2020) LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis. Cell Death Dis 11(4):278. https://doi.org/10.1038/s41419-020-2485-1CrossRefPubMedPubMedCentral

Titel: Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma
verfasst von: Haixia Wang
Tianliang Yu
Limin Mao
Publikationsdatum: 26.11.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 7/2022
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-021-07181-x

Distinct microbiota dysbiosis in patients with laryngopharynx reflux disease compared to healthy controls

Laryngology

Identifying epithelial borders in cholesteatoma surgery using narrow band imaging

Open Access
Otology

Long-lasting olfactory dysfunction in COVID-19 patients

Open Access
COVID-19
Rhinology

Diagnosis of possible nasopharyngeal malignancy in adults with isolated serous otitis media; a systematic review and proposal of a management algorithm

Review Article

Remote assessments for bone conduction hearing devices during the COVID-19 pandemic

Zur Zeit gratis
COVID-19
Otology

Cochlear implantation among patients with otosclerosis: a systematic review of clinical characteristics and outcomes

Otology

Neu im Fachgebiet HNO

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

12.01.2025
Elektronische Patientenakte
Nachrichten

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Kopf-Hals-Tumore: Lebensqualität von Langzeitüberlebenden

08.01.2025
HNO-Tumoren
Nachrichten

Eine aktuelle Studie des Universitätsklinikums Erlangen verdeutlicht, dass Langzeitüberlebende von Kopf-Hals-Tumoren eine geringe Symptomlast aufweisen. Die am häufigsten auftretenden Beschwerden – Müdigkeit, Angstzustände, Schläfrigkeit und Schmerzen – sollten von den behandelnden Ärztinnen und Ärzten gezielt adressiert werden.

Schlafapnoe – es lag an einer verbogenen Nasenscheidewand

07.01.2025
Obstruktive Schlafapnoe
Nachrichten

Tritt eine obstruktive Schlafapnoe vor allem in einer bestimmten Seitenlage auf, kann dies auch an einem verbogenen Nasenseptum liegen. Eine Septumplastik lindert die Beschwerden mitunter deutlich.

Das alles ändert sich für Arztpraxen in 2025

31.12.2024
EBM
Nachrichten

Ab Januar greifen jede Menge Neuerungen – ob im EBM, Arbeits- und Steuerrecht oder bei der digitalen Vernetzung. Darunter einige Verbesserungen, aber teils auch Mehraufwand. „Same procedure as every year?“ – Ein Überblick.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma

Abstract

Background

Methods

Results

Conclusion

Weitere Artikel der Ausgabe 7/2022

Distinct microbiota dysbiosis in patients with laryngopharynx reflux disease compared to healthy controls

Identifying epithelial borders in cholesteatoma surgery using narrow band imaging

Long-lasting olfactory dysfunction in COVID-19 patients

Diagnosis of possible nasopharyngeal malignancy in adults with isolated serous otitis media; a systematic review and proposal of a management algorithm

Remote assessments for bone conduction hearing devices during the COVID-19 pandemic

Cochlear implantation among patients with otosclerosis: a systematic review of clinical characteristics and outcomes

Neu im Fachgebiet HNO

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Kopf-Hals-Tumore: Lebensqualität von Langzeitüberlebenden

Schlafapnoe – es lag an einer verbogenen Nasenscheidewand

Das alles ändert sich für Arztpraxen in 2025

Update HNO

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten